Zoetis Inc 8-K, filed Nov 5, 2026

Zoetis Inc. (ZTS)

8-K 2026-11-05 For: 2026-11-05

Added on November 05, 2026

About this 8-K

Zoetis Inc filed this 8-K on November 5, 2026.

Zoetis reported revenue of $2.4 billion, down 1%, and adjusted diluted EPS of $1.75, up 3%. It narrowed full year 2026 revenue guidance and raised adjusted diluted EPS guidance to $6.25 to $6.35. AI summary

Items reported

Item 2.02: Financial results
Item 9.01: Financial statements and exhibits

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →


Exhibit No.			Description

99.1			Press Release of Zoetis Inc. dated November 5, 2026, reporting Zoetis' financial results for the
			third quarter of 2026 and its guidance for full year 2026.
EX-101.INS			Inline XBRL INSTANCE DOCUMENT
EX-101.SCH			Inline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL			Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LAB			Inline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE			Inline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEF			Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
104			Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


	Zoetis Inc.

November 5, 2026	By:	/S/ JAY SACCARO
		Jay Saccaro
		Executive Vice President, Chief Financial Officer and Chief Operating Officer


Media Contacts:						Investor Contacts:
Jennifer Albano						Mathieu Aussermeier
1-862-399-0810 (o)						1-862-460-0181 (o)
jennifer.albano@zoetis.com						mathieu.aussermeier@zoetis.com

Laura Panza						Nick Soonthornchai
1-973-975-5176 (o)						1-973-443-2792 (o)
laura.panza@zoetis.com						nick.soonthornchai@zoetis.com


	Three Months Ended					Nine Months Ended
	September 30,					September 30,
	2026		2025		% Change	2026		2025		% Change
Revenue	$	2,391	$	2,422	(1)	$	7,121	$	7,094	—
Costs and expenses:
Cost of sales	698		697		—	2,012		1,979		2
Selling, general and administrative expenses	582		582		—	1,762		1,770		—
Research and development expenses	174		175		(1)	527		503		5
Amortization of intangible assets	31		32		(3)	93		97		(4)
Restructuring charges and certain acquisition and divestiture-related costs	43		4		*	142		34		*
Interest expense, net of capitalized interest	62		58		7	185		165		12
Other (income)/deductions–net	72		(12)		*	47		(25)		*
Income before provision for taxes on income	729		886		(18)	2,353		2,571		(8)
Provision for taxes on income	138		165		(16)	470		522		(10)
Net income before allocation to noncontrolling interests	591		721		(18)	1,883		2,049		(8)
Less: Net income/(loss) attributable to noncontrolling interests	—		—		*	—		—		*
Net income attributable to Zoetis Inc.	$	591	$	721	(18)	$	1,883	$	2,049	(8)

Earnings per share attributable to Zoetis—basic	$	1.44	$	1.63	(12)	$	4.51	$	4.60	(2)


Earnings per share attributable to Zoetis—diluted	$	1.44	$	1.63	(12)	$	4.51	$	4.60	(2)


Weighted-average shares used to calculate earnings per share
Basic	411.6		442.9			417.1		445.2
Diluted	411.6		443.2			417.3		445.6


ZOETIS INC.
RECONCILIATION OF GAAP REPORTED TO NON-GAAP ADJUSTED INFORMATION
CERTAIN LINE ITEMS
(UNAUDITED)
(millions of dollars, except per share data)

	Three Months Ended September 30, 2026
	GAAP Reported		Purchase Accounting Adjustments		Acquisition and Divestiture- Related Costs(1)		Certain Significant Items(2)		Non-GAAP Adjusted(a)

Cost of sales	$	698	$	(1)	$	—	$	(3)	$	694

Gross profit	1,693		1		—		3		1,697
Selling, general and administrative expenses	582		(3)		—		(8)		571

Amortization of intangible assets	31		(27)		—		—		4
Restructuring charges and certain acquisition and divestiture-related costs	43		—		(2)		(41)		—

Other (income)/deductions–net	72		—		—		(81)		(9)
Income before provision for taxes on income	729		31		2		133		895
Provision for taxes on income	138		7		—		30		175


Net income attributable to Zoetis	591		24		2		103		720
Earnings per common share attributable to Zoetis–diluted	1.44		0.06		—		0.25		1.75

	Three Months Ended September 30, 2025
	GAAP Reported		Purchase Accounting Adjustments		Acquisition and Divestiture- Related Costs(1)		Certain Significant Items(2)		Non-GAAP Adjusted(a)

Cost of sales	$	697	$	(1)	$	—	$	(1)	$	695

Gross profit	1,725		1		—		1		1,727
Selling, general and administrative expenses	582		(3)		—		(7)		572
Research and development expenses	175		(1)		—		—		174
Amortization of intangible assets	32		(27)		—		—		5
Restructuring charges and certain acquisition and divestiture-related costs	4		—		—		(4)		—

Other (income)/deductions–net	(12)		—		—		4		(8)
Income before provision for taxes on income	886		32		—		8		926
Provision for taxes on income	165		8		—		(1)		172


Net income attributable to Zoetis	721		24		—		9		754
Earnings per common share attributable to Zoetis–diluted	1.63		0.05		—		0.02		1.70

(a) Non-GAAP adjusted net income and its components and non-GAAP adjusted diluted EPS are not, and should not be viewed as, substitutes for U.S. GAAP net income and its components and diluted EPS. Despite the importance of these measures to management in goal setting and performance measurement, non-GAAP adjusted net income and its components and non-GAAP adjusted diluted EPS are non-GAAP financial measures that have no standardized meaning prescribed by U.S. GAAP and, therefore, have limits in their usefulness to investors. Because of the non-standardized definitions, non-GAAP adjusted net income and its components and non-GAAP adjusted diluted EPS (unlike U.S. GAAP net income and its components and diluted EPS) may not be comparable to the calculation of similar measures of other companies. Non-GAAP adjusted net income and its components, and non-GAAP adjusted diluted EPS are presented solely to permit investors to more fully understand how management assesses performance.
See Notes to Reconciliation of GAAP Reported to Non-GAAP Adjusted Information for notes (1) and (2).


Zoetis Inc.
(Exact name of registrant as specified in its charter)


Not Applicable
(Former Name or Former Address, if changed since last report)


Selected Line Items (millions of dollars, except per share amounts)	Full Year 2026 as of November 5, 2026	Full Year 2026 as of August 6, 2026 (Prior Guidance)
Revenue	$9,220 to $9,320	$9,120 to $9,320
Organic operational results(a)	(2)% to (1)%	(3)% to (1)%
Adjusted cost of sales as a percentage of revenue(b)	Approximately 29.0%	Approximately 29.0%
Adjusted SG&A expenses(b)	$2,340 to $2,370	$2,330 to $2,380
Adjusted R&D expenses(b)	$705 to $715	$720 to $730
Adjusted interest expense and other (income)/deductions-net(b)	Approximately $215	Approximately $215
Effective tax rate on adjusted income(b)	Approximately 20%	Approximately 20.5%
Adjusted diluted EPS(b)	$6.25 to $6.35	$6.15 to $6.25
Adjusted net income(b)	$2,600 to $2,640	$2,570 to $2,620
Organic operational results(a)(c)	(7)% to (5)%	(9)% to (5)%
Certain significant items and acquisition and divestiture-related costs(d)	Approximately $210	Approximately $150
Reported diluted EPS	$5.50 to $5.60	$5.55 to $5.65


ZOETIS INC. CONSOLIDATED REVENUE BY SEGMENT(a) AND SPECIES (UNAUDITED) (millions of dollars)



	Three Months Ended
	September 30,				% Change
	2026		2025		Reported Change		Foreign Exchange		Operational(b)		Divestitures		Organic Operational(c)
Revenue:
Companion Animal	$	1,565	$	1,650	(5)	%	—	%	(5)	%	—	%	(5)	%
Livestock	797		746		7	%	1	%	6	%	(1)	%	7	%
Contract Manufacturing & Human Health	29		26		12	%	(3)	%	15	%	—	%	15	%
Total Revenue	$	2,391	$	2,422	(1)	%	1	%	(2)	%	(1)	%	(1)	%

U.S.:
Companion Animal	$	980	$	1,069	(8)	%	—	%	(8)	%	—	%	(8)	%
Livestock	266		253		5	%	—	%	5	%	—	%	5	%
Total U.S. Revenue	$	1,246	$	1,322	(6)	%	—	%	(6)	%	—	%	(6)	%

International:
Companion Animal	$	585	$	581	1	%	1	%	—	%	—	%	—	%
Livestock	531		493		8	%	2	%	6	%	(3)	%	9	%
Total International Revenue	$	1,116	$	1,074	4	%	1	%	3	%	(1)	%	4	%

Companion Animal:
Dogs and Cats	$	1,492	$	1,581	(6)	%	—	%	(6)	%
Horses	73		69		6	%	—	%	6	%
Total Companion Animal Revenue	$	1,565	$	1,650	(5)	%	—	%	(5)	%

Livestock:
Cattle	$	439	$	415	6	%	1	%	5	%
Swine	120		116		3	%	1	%	2	%
Poultry	108		106		2	%	(1)	%	3	%
Fish	98		80		23	%	5	%	18	%
Sheep and other	32		29		10	%	4	%	6	%
Total Livestock Revenue	$	797	$	746	7	%	1	%	6	%

(a) For a description of each segment, see Zoetis' most recent Annual Report on Form 10-K.
(b) Operational revenue results (a non-GAAP financial measure) is defined as revenue results excluding the impact of foreign exchange.
(c) Organic operational revenue results (a non-GAAP financial measure) is defined as revenue results excluding the impact of foreign exchange and certain acquisitions and divestitures.


ZOETIS INC. SEGMENT(a) EARNINGS (UNAUDITED) (millions of dollars)



	Three Months Ended
	September 30,						% Change
	2026			2025			Reported Change		Foreign Exchange		Operational(b)
U.S.:
Revenue	$	1,246		$	1,322		(6)	%	—	%	(6)	%
Cost of Sales	222			222			—	%	—	%	—	%
Gross Profit	1,024			1,100			(7)	%	—	%	(7)	%
Gross Margin	82.2		%	83.2		%
Operating Expenses	194			201			(3)	%	—	%	(3)	%
Other (income)/deductions-net	—			—			*		*		*
U.S. Earnings	$	830		$	899		(8)	%	—	%	(8)	%

International:
Revenue	$	1,116		$	1,074		4	%	1	%	3	%
Cost of Sales	347			342			1	%	—	%	1	%
Gross Profit	769			732			5	%	2	%	3	%
Gross Margin	68.9		%	68.2		%
Operating Expenses	169			169			—	%	1	%	(1)	%
Other (income)/deductions-net	—			—			*		*		*
International Earnings	$	600		$	563		7	%	2	%	5	%

Total Reportable Segments	$	1,430		$	1,462		(2)	%	1	%	(3)	%

Other business activities(c)	(134)			(143)			(6)	%
Reconciling Items:
Corporate(d)	(303)			(304)			—	%
Purchase accounting adjustments(e)	(31)			(32)			(3)	%
Acquisition and divestiture-related costs(f)	(2)			—			*
Certain significant items(g)	(133)			(8)			*
Other unallocated(h)	(98)			(89)			10	%
Total Earnings(i)	$	729		$	886		(18)	%

(a) For a description of each segment, see Zoetis' most recent Annual Report on Form 10-K.
(b) Operational results (a non-GAAP financial measure) is defined as results excluding the impact of foreign exchange.
(c) Other business activities includes the research and development costs managed by our research and development organization, as well as our contract manufacturing business and human health business.
(d) Corporate includes, among other things, certain costs associated with information technology, administration expenses, interest income and expense, certain compensation costs and other costs not charged to our operating segments.
(e) Purchase accounting adjustments include certain charges related to the amortization of fair value adjustments to inventory, intangible assets and property, plant and equipment not charged to our operating segments.
(f) Acquisition and divestiture-related costs include costs associated with acquiring and integrating newly acquired businesses, such as transaction costs and integration costs, as well as costs associated with divesting and disintegrating a portion of our business.
(g) Certain significant items includes substantive, unusual items that, either as a result of their nature or size, would not be expected to occur as part of our normal business on a regular basis. Such items primarily include certain asset impairment charges, restructuring charges and implementation costs associated with cost-reduction/productivity initiatives that are not associated with an acquisition, costs related to our business process transformation program, as well as the impact of divestiture gains and losses.
(h) Includes overhead expenses associated with our global manufacturing and supply operations not directly attributable to an operating segment, as well as certain procurement costs.
(i) Defined as income before provision for taxes on income.
* Calculation not meaningful.



FORM			8-K


(Registrant's telephone number, including area code)